Invizyne (EXOZ) - Long-Term Debt to Capital Coefficient

The eXoZymes Inc (EXOZ) chart on the GURU.Markets platform reflects the dynamics of a company establishing biochemical capacities through partnerships with plants, where the indicator stands at 0.18. A lack of profitability and a reliance on investment make the enzyme development stage extremely risky. The business relies on outsourcing production and cloud computing for AI training, functioning as an advanced research center.

To minimize fundamental risks, investors evaluate the long-term debt-to-equity ratio, which determines the degree of financial leverage and the company's reliance on external borrowings with maturities exceeding one year. Analyzing the long-term debt-to-equity structure reveals the extent to which the scaling of biochemical developments at eXoZymes Inc. (EXOZ) relies on borrowed funds versus internal resources during the expansion of green chemistry.